Eric Wayne Golightly

Array ( [id] => 3974599 [patent_doc_number] => 05958336 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Surface sterilization device' [patent_app_type] => 1 [patent_app_number] => 8/638144 [patent_app_country] => US [patent_app_date] => 1996-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 7714 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958336.pdf [firstpage_image] =>[orig_patent_app_number] => 638144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842355 [patent_doc_number] => 05707963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Methods of using growth inhibitory peptides' [patent_app_type] => 1 [patent_app_number] => 8/636386 [patent_app_country] => US [patent_app_date] => 1996-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9743 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707963.pdf [firstpage_image] =>[orig_patent_app_number] => 636386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827468 [patent_doc_number] => 05739008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'DNA encoding a protein comprising calmodulin-and actin-binding human caldesmon peptide fragment' [patent_app_type] => 1 [patent_app_number] => 8/630349 [patent_app_country] => US [patent_app_date] => 1996-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9157 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739008.pdf [firstpage_image] =>[orig_patent_app_number] => 630349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932880 [patent_doc_number] => 05972624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Method of identifying ligands which bind recombinant galanin receptor (GALR2)' [patent_app_type] => 1 [patent_app_number] => 8/626685 [patent_app_country] => US [patent_app_date] => 1996-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 9 [patent_no_of_words] => 25137 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972624.pdf [firstpage_image] =>[orig_patent_app_number] => 626685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945695 [patent_doc_number] => 05977077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Xanthone analogs for the treatment of infectious diseases' [patent_app_type] => 1 [patent_app_number] => 8/619063 [patent_app_country] => US [patent_app_date] => 1996-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6654 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977077.pdf [firstpage_image] =>[orig_patent_app_number] => 619063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831627 [patent_doc_number] => 05760259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Tetradecadienoic acid, a glycosyl phosphatidylinositol (GPI) analogue used for inhibiting parasitic activity' [patent_app_type] => 1 [patent_app_number] => 8/617246 [patent_app_country] => US [patent_app_date] => 1996-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 32 [patent_no_of_words] => 16891 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760259.pdf [firstpage_image] =>[orig_patent_app_number] => 617246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1368795 [patent_doc_number] => 06566326 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Chemically modified hemoglobin for burn shock resuscitation' [patent_app_type] => B1 [patent_app_number] => 08/615058 [patent_app_country] => US [patent_app_date] => 1996-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3486 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566326.pdf [firstpage_image] =>[orig_patent_app_number] => 08615058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235606 [patent_doc_number] => 06090576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'DNA encoding a transferrin receptor of Moraxella' [patent_app_type] => 1 [patent_app_number] => 8/613009 [patent_app_country] => US [patent_app_date] => 1996-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 30311 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090576.pdf [firstpage_image] =>[orig_patent_app_number] => 613009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837849 [patent_doc_number] => 05744324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Nucleic acids encoding potassium channels which form inward rectifier, G-protein activated, mammalian, heteromultimeric, potassium channels and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/614801 [patent_app_country] => US [patent_app_date] => 1996-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 11736 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744324.pdf [firstpage_image] =>[orig_patent_app_number] => 614801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3875956 [patent_doc_number] => 05728552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'DNA encoding a fusion protein comprising a viral antigen and lymphokine' [patent_app_type] => 1 [patent_app_number] => 8/600545 [patent_app_country] => US [patent_app_date] => 1996-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 22 [patent_no_of_words] => 13089 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728552.pdf [firstpage_image] =>[orig_patent_app_number] => 600545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1112659 [patent_doc_number] => 06803188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Tandem fluorescent protein constructs' [patent_app_type] => B1 [patent_app_number] => 08/594575 [patent_app_country] => US [patent_app_date] => 1996-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 10737 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803188.pdf [firstpage_image] =>[orig_patent_app_number] => 08594575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804133 [patent_doc_number] => 05830760 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Creating novel hematopoietic cell lines by expressing altered retinoic acid receptors' [patent_app_type] => 1 [patent_app_number] => 8/592383 [patent_app_country] => US [patent_app_date] => 1996-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 64 [patent_no_of_words] => 23204 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830760.pdf [firstpage_image] =>[orig_patent_app_number] => 592383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871325 [patent_doc_number] => 05763400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Ecdysis-triggering hormone compositions' [patent_app_type] => 1 [patent_app_number] => 8/582257 [patent_app_country] => US [patent_app_date] => 1996-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 27716 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763400.pdf [firstpage_image] =>[orig_patent_app_number] => 582257 [rel_patent_id] =>[rel_patent_doc_number] =>)